Novonesis provided sales guidance for the year 2024. For the year, the company expects 5% to 7% organic sales growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
419.9 DKK | -0.50% | +2.92% | +13.15% |
May. 10 | NOVONESIS : Key segments outperform in average Q1 24 showing | |
May. 03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.15% | 28.4B | |
-14.02% | 3.79B | |
+12.37% | 1.79B | |
-10.77% | 637M | |
-27.39% | 390M | |
-81.65% | 216M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novonesis Provides Sales Guidance for the Year 2024